Literature DB >> 28255551

Multiple perforations and fistula formation following corticosteroid administration: A case report.

Jing-Ni He1, Zhong Tian1, Xu Yao1, Hang-Yu Li1, Yun Yu1, Yuan Liu1, Jin-Gang Liu1.   

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic small- and medium-sized-vessel vasculitis. The literature contains only a few reports of gastrointestinal perforation with this condition. We report a patient with EPGA treated with high-dose steroid who underwent emergency surgery for intestinal perforations. We performed a simple repair of the 11 perforations. Intestinal fistulas developed 8 d postoperatively; they healed well after 60 d of continuous washing and negative pressure suction. The clinical data of 14 additional patients with EGPA or Churg-Strauss syndrome complicated with gastrointestinal perforation, which were reported from 1996 to 2014, were also collected and compared. The formation of multiple perforations and fistulas following high dosage steroid administration can have a good outcome with appropriate management. Meticulous attention to abdominal symptoms and appropriate interventions can result in timely management. Corticosteroid administration remains a very important perioperative procedure for EPGA.

Entities:  

Keywords:  Churg-Strauss syndrome; Eosinophilic granulomatosis with polyangiitis; Gastrointestinal perforation; Surgery; Vasculitis

Year:  2017        PMID: 28255551      PMCID: PMC5314264          DOI: 10.12998/wjcc.v5.i2.67

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


Core tip: Eosinophilic granulomatosis with polyangiitis (EGPA) complicated with intestinal perforation is very rare. It needs urgent surgical intervention but hormone administration usually covers up the situation and delays the prognosis. We report a 43-year-old male diagnosed with EGPA by biopsy who experienced high-dose hormone administration, 11 intestinal perforations, postoperative intestinal fistula, and eventually recovered. This article aims to share the treatment course and experience.

INTRODUCTION

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare type of necrotizing vasculitis affecting small to medium-sized vessels. It is typically characterized by asthma, lung infiltrates, necrotizing granulomas, and hypereosinophilia. It is an uncommon form of vasculitis with a prevalence that ranges from 10.7 to 13 cases/million[1]. Gastrointestinal involvement has been reported to occur in approximately 50% of EGPA patients. Symptoms include abdominal pain, vomiting and diarrhea[2]. Although EGPA very easily involves the digestive system, the chance of digestive tract perforation is very low and only a handful of cases have been reported. We report a case of EGPA with 11 intestinal perforations, and discuss the subsequent treatment.

CASE REPORT

A 43-year-old male with a 3-mo history of asthma was admitted to the Rheumatoid Immune Department of Shengjing Hospital in July 2013. The patient complained of a cough of one-month duration, blood-stained sputum, 14-d peripheral purpura, 3-d diarrhea, and an oral ulcer. His height was 176 cm and weight was 72 kg when admission. His temperature was 37.2 °C, his pulse was 78 per minute, and his blood pressure was 128/78 mmHg. Multiple skin purpura was found in the physical examination. Heart sounds were clear and regular with no murmur. A few moist rales were heard with lung auscultation. Abdominal examination was unremarkable. Laboratory studies revealed leukocytosis (15600/mm3) with eosinophilia (20.3%), a marked increase in inflammatory indices (ESR: 69 mm at the first hour; CRP: 176 mg/L), rheumatoid factor (656 UI/mL), and positive pANCA antibody. A pulmonary computed tomography (CT) scan revealed multiple low-density oval shadows, with the largest one measuring about 3.2 cm × 2.6 cm (Figure 1). A diagnosis of vasculitis was made. A biopsy of the nasal mucosa revealed an eosinophilic infiltration. We diagnosed EGPA according to the revised international Chapel Hill nomenclature. The patient received methylprednisolone (120 mg intravenously daily) and ifosfamide for the treatment of the pulmonary lesions. The patient’s condition exacerbated during the first three days following admission; the methylprednisolone dose was increased to 500 mg (intravenously daily × 2) and then was gradually tapered. On the 13th day after admission (160 mg methylprednisolone intravenously daily), he experienced a sudden onset of fever and abdominal pain. The physical examination revealed generalized abdominal tenderness without apparent rebound tenderness, and muscle tension. No specific treatment was given. After 11 h, the abdominal pain exacerbated and peritonitis developed. An abdominal CT scan showed an amount of free gas in the abdominal cavity (Figure 2). A laparotomy was performed immediately, which revealed scattered eleven perforations in the intestine. The proximal one was located approximately 150 cm distal from the ligament of Treitz ligament, and the distal one located approximately 50 cm from the ileocecal valve, with the largest measuring about 3 cm × 3 cm (Figure 3). Considering the high risk of short bowel syndrome, we made a simple repair of the intestinal perforations. Histopathological examination did not reveal either eosinophilic infiltration or granuloma formation of the vessels (Figure 4).
Figure 1

Pulmonary computed tomography images showing bilateral consolidation with air-bronchogram, especially in the right lung with multiple ground glass low-density shadows.

Figure 2

Abdominal transverse computed tomography images. A: Free air in the abdomen and fluid around the liver; B: Intestinal wall thickening in the right lower quadrant and seepage, scattered with free air.

Figure 3

Introperative findings. There were 11 perforations in the intestine. The arrow points to the bigger one measuring about 3 cm × 3 cm.

Figure 4

Histopathological examination showing a large number of infiltrated inflammatory cells (HE staining, × 100).

Pulmonary computed tomography images showing bilateral consolidation with air-bronchogram, especially in the right lung with multiple ground glass low-density shadows. Abdominal transverse computed tomography images. A: Free air in the abdomen and fluid around the liver; B: Intestinal wall thickening in the right lower quadrant and seepage, scattered with free air. Introperative findings. There were 11 perforations in the intestine. The arrow points to the bigger one measuring about 3 cm × 3 cm. Histopathological examination showing a large number of infiltrated inflammatory cells (HE staining, × 100). Continued intravenous therapy with intermittent ifosfamide as well as somatostatin and esomeprazole was administered postoperatively. The hormone dosage was tapered from 160 mg downward. On postoperative day 6, when the steroid was reduced to 80 mg, the patient’s vasculitis exacerbated and he developed fever and new purpura on the entire body. Eight days postoperatively, an intestinal fistula developed, which was confirmed by fistulography (Figure 5). With continuous saline washing through a double-lumen cannula connected to a negative pressure suction apparatus, the drainage was about 300 mL intestinal fluid daily; the fistula slowly healed. The patient began eating on postoperative day 45. Gastric retention occurred after eating; it was treated with decompression via a nasogastric tube, total parenteral nutrition, and a gastric motility stimulating agent. The patient resumed eating about two months postoperatively, and the drainage was minimal. When the steroid dosage was reduced to 60 mg intravenously, the fistula healed and the patient was discharged.
Figure 5

Fistulography showing that after injection of contrast agents, the intestine of the right lower quadrant abdomen developed a fistula.

Fistulography showing that after injection of contrast agents, the intestine of the right lower quadrant abdomen developed a fistula. Unfortunately, four months later, an intestinal fistula and vasculitis recurred. Although the amount was 5 mL daily, he was readmitted and underwent continuous washing and negative pressure suction. The fistula healed slowly during one month. When last seen in the outpatient clinic in March 2014, he was in good health without any symptoms or eosinophilia. Laboratory analysis revealed 0.1% eosinophils and negative pANCA antibodies.

DICUSSION

EGPA, formerly named churg-strauss syndrome (CSS), is characterized by the presence of severe asthma as well as blood and tissue eosinophilia. It is an uncommon form of vasculitis, with a prevalence that ranges from 10.7 to 13 cases/million. Although it is classified as vasculitis, the affected tissue usually does not show necrotizing vasculitis or granulomata, rather an apparently nondestructive infiltration of the vessel walls by eosinophils; in fact, only 40%-60% of patients with CSS have anti-neutrophil cytoplasmic antibodies (ANCAs)[3]. For this reason the diagnostic criteria remain clinical. Gastrointestinal involvement is present in 32.6% of CSS patients. In 29.11% of the cases, the large bowel is involved, in 53.5%, the small bowel is involved, in 16.6%, the gastroduodenal region is involved, and in 6.3%, pancreatitis and cholecystitis occur. The mortality rate is 11.9%[4-6]. Although gastrointestinal symptoms are common, perforated ulcers are relatively uncommon and only a small number of cases have been documented in the literature[7]. Because multiple organs are involved and peritonitis symptoms are not typical, complicated clinical manifestations occur, which delays treatment and results in a poor prognosis. A systematic review of the literature was performed using the keywords “Churg-Strauss syndrome/eosinophilic granulomatosis with polyangiitis” and “gastrointestinal perforation” in PubMed to search articles from 1951 to December 2014. In China, CSS/EGPA with gastrointestinal perforation is very rare, and there is no relevant report. The articles were restricted to English language only. Duplicate reports and papers with important data missing were excluded. We included the papers on digestive tract perforation with CSS/EGPA, and compared the characteristics (Table 1). The average patient age was 46.3 years (range: 16-72 years; males: 10; females: 4). A half of the patients were complicated with the symptom of asthma, and all of them had received corticosteroid treatment. Their prognosis was poor, with 4/13 (30.77%; case 13 was unknown) dying during hospitalization, although the causes of death were very different. A second perforation of the digestive system occurred in 2 (15.38%) of 13 patients (case 13 was unknown).
Table 1

Summary of cases of Churg-Strauss syndrome/eosinophilic granulomatosis with polyangiitis with digestive perforation in the English literature

Ref.yearAge/sexInitial symptomsWBC (/mm3)Eosino (%)HormonePerforationtreatmentHistologySecond perforationPrognosis
Ikoma et al[10]201419/femaleAsthma2470039YesIleumAnastomosisTransmural infiltration of numerous eosinophils with thrombosis and extensive involvement of small arteriesNoAlive
Kaul et al[11]201458/maleLow-grade fever9400042YesIleo-caecal junctionIleostomyTransmural inflammation of sub-mucosal and serosal vessels with perivascular infiltrate comprising of lymphomononuclear cells and eosinophilsNoAlive
Assmann et al[12]201432/maleDyspnea, fatigue, fever and chest pain-5500/lYes + cyclophosphamideMiddle part of jejunumAnastomosis-NoAlive
Assmann et al[12]201436/maleDyspnea, fatigue, fever and chest pain-4900/lYes + cyclophosphamideColon transversumAnastomosisEosinophilic infiltration and thrombotic vessel occlusionNoAlive
Çiledağ et al[8]201235/maleAnorexia-35YesSmall intestineRepair-NoDied
Venditti et al[13]201169/maleAbdominal pain--YesRight and transverse colonIleostomyMultiple ulcers, extravasal granulomas and mucosal pseudopolypsNoAlive
Zanaboni et al[14]200843/maleAsthma3200065YesSmall intestineAnastomosisNecrotizing ischemic vasculitis with inflammatory granulomatous infiltrates of lymphocytes, polymorphonuclear cells and eosinophilsYesAlive
Rolla et al[15]200755/maleAsthma1550021YesIleumAnastomosisGranulomatous vasculitis with eosinophilic infiltrationNoAlive
Murakami et al[5]200451/femaleAsthma2765062YesIleumAnastomosisAngiitis of small vessels surrounded by eosinophilic infiltration and granuloma of the vesselsNoDied
Nagashima et al[16]200267/maleAsthma1850065YesIntestineAnastomosisVasculitis in the small arteries and arterioles characterized by thrombotic occlusion with fibrinoid necrosis of the vascular wall and prominent inflammatory cell infiltration in the perivascular regionNoAlive
Nakamura et al[17]200231/maleEpigastralgia1970040YesJejunum and ileumAnastomosisMultiple ulcerative lesions with remarkable eosinophilic infiltration and thrombosis obstruction of small vesselsNoAlive
Alvarez et al[18]200264/femaleUrticaria, recurrent rhinitis, and asthma1000034YesIntestineAnastomosisWall ulcerations, vascular thrombosis with fibrinoid necrosis, and eosinophilic infiltratesYesDied
Kim et al[4]200072/femaleAsthma660014YesSigmoid colonAnastomosisUlceration with heavy infiltrations of eosinophils, neutrophils and lymphoplasma cells--
Sharma et al[19]199616/maleLow-grade, continuous fever and wheezing sounds in the chest1260070YesJejunumAnastomosisNecrotizing vasculitis with marked eosinophilic infiltration of medium-to-small blood vessels and extravascular granulomasNoDied
Summary of cases of Churg-Strauss syndrome/eosinophilic granulomatosis with polyangiitis with digestive perforation in the English literature Ulceration, perforation, and stenosis of the gastrointestinal tract are assumed to be the results of ischemia caused by vasculitis. The small intestine is the most commonly affected site[8]. Immunosuppressive therapy, especially large-dosage corticosteroids, may play an important role in the development of an intestinal perforation. However, sometimes, it is difficult to distinguish clinically whether the intestinal perforation is due to vasculitis itself or immunosuppression[9]. Treatment of a gastrointestinal perforation in patients with active vasculitis can be challenging. A delayed diagnosis may lead to a delayed cure, as in our patient. First, we did not pay adequate attention to the digestive symptoms: Sour regurgitation, heartburn, and abdominal pain. Second, the symptoms of peritonitis are often atypical in patients receiving long-term administration of glucocorticoids. Third, when the digestive tract perforation occurred, the patient was in the rheumatic ward. As a result of consultation, diagnosis, and department transference, treatment delay can occur. Fourth, the gastrointestinal perforation may occur during a clinical remission. The perforation of this case occurred during the process of steroid tapering. Pathologic examination of the perforated bowel revealed no significant eosinophil infiltration. In conclusion, improved awareness of gastrointestinal symptoms may allow for timely management of a perforation. Multiple perforations and fistulas caused by high dosage steroids can have a good outcome with appropriate management. Prompt surgical treatment is necessary. The choice of the appropriate surgical approach should be based on the time the perforations occurred, their size, numbers, and sites. Adequate steroid administration and intensive care play an important role during perioperative treatment.

COMMENTS

Case characteristics

A 43-year-old male with a 3-mo history of asthma, a cough of one-month duration, blood-stained sputum, 14 d of peripheral purpura, 3 d of diarrhea, and an oral ulcer. On the 13th day after admission, the patient experienced a sudden onset of fever and abdominal pain. And the abdominal pain exacerbated and peritonitis developed rapidly.

Clinical diagnosis

History of asthma, peripheral purpura, and peritonitis.

Differential diagnosis

Granulomatosis with polyangiitis, microscopic polyangitis, and polyarteritis nodosa.

Laboratory diagnosis

Laboratory studies revealed leukocytosis (15600/mm3) with eosinophilia (20.3%), a marked increase in inflammatory indices (ESR: 69 mm at the first hour; CRP: 176 mg/L), rheumatoid factor (656 UI/mL), and positive pANCA antibody.

Imaging diagnosis

A pulmonary computed tomography (CT) scan revealed multiple low-density oval shadows, with the largest one measuring about 3.2 cm × 2.6 cm. An abdominal CT scan showed free air in the abdomen.

Pathological diagnosis

A biopsy of the nasal mucosa revealed an eosinophilic infiltration.

Treatment

Continued intravenous hormone therapy with intermittent ifosfamide perioperatively, and intestinal perforation repair.

Related reports

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare type of necrotizing vasculitis affecting small to medium-sized vessels; it is typically characterized by asthma, lung infiltrates, necrotizing granulomas, and hypereosinophilia. Gastrointestinal involvement even perforation is more unusual and results in a poor prognosis.

Term explanation

EGPA with multiple intestinal perforations is very rare. Prompt surgical treatment is necessary. Adequate steroid administration and intensive care play an important role during perioperative treatment.

Experiences and lessons

Reasonable amount of hormone administration is the key point during the treatment. Excess hormone may induce intestinal perforation while insufficient amount could induce disease relapse and intestinal fistula postoperatively.

Peer-review

This is an interesting case report and the paper is well written.
  19 in total

1.  Churg Strauss syndrome presenting as acute neuropathy resembling Guillain Barré syndrome: case report.

Authors:  Nilo Riva; Federica Cerri; Calogera Butera; Stefano Amadio; Angelo Quattrini; Raffaella Fazio; Mauro Comola; Giancarlo Comi
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

2.  Crescentic glomerulonephritis in non-asthmatic Churg-Strauss syndrome.

Authors:  Anupma Kaul; Raj Kumar Sharma; Krishna Swamy Jaisuresh; Vinita Agrawal
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-03

3.  Perforation of small intestine caused by Churg-Strauss syndrome.

Authors:  M C Sharma; R Safaya; B S Sidhu
Journal:  J Clin Gastroenterol       Date:  1996-10       Impact factor: 3.062

4.  Delayed relapse of Churg-Strauss syndrome manifesting as colon ulcers with mucosal granulomas: 3 cases.

Authors:  Nathalie Mémain; Bandt Michel De; Loïc Guillevin; Bertrand Wechsler; Olivier Meyer
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

Review 5.  Multiple perforated ulcers of the small intestine associated with allergic granulomatous angiitis: report of a case.

Authors:  Yasuko Nakamura; Yoichi Sakurai; Toshiki Matsubara; Tomohito Nagai; Shusaku Fukaya; Hiroki Imazu; Shigeru Hasegawa; Masahiro Ochiai; Takahiko Funabiki; Yoshikazu Mizoguchi; Makoto Kuroda
Journal:  Surg Today       Date:  2002       Impact factor: 2.549

6.  Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome.

Authors:  Toshiko Nagashima; Bingzhen Cao; Naoto Takeuchi; Takayo Chuma; Yukio Mano; Matoko Fujimoto; Mitsuru Nunomura; Taro Oshikiri; Kyohsuke Miyazaki; Mituru Dohke; Nobukazu Kashimura; Toshiya Shinohara; Yasuko Orba; Shin Ishizawa; Kazuo Nagashima
Journal:  Neuropathology       Date:  2002-12       Impact factor: 1.906

Review 7.  Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome).

Authors:  Luc Mouthon; Bertrand Dunogue; Loïc Guillevin
Journal:  J Autoimmun       Date:  2014-02-12       Impact factor: 7.094

8.  An aggressive and lethal course of Churg-Strauss syndrome with alveolar hemorrhage, intestinal perforation, cardiac failure and peripheral neuropathy.

Authors:  Aydin Çiledağ; Hülya Deniz; Serpil Eledağ; Canan Özkal; Nurşen Düzgün; Selim Erekul; Demet Karnak
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 3.580

9.  Churg-Strauss syndrome with perforating ulcers of the colon.

Authors:  Y B Kim; S W Choi; I S Park; J Y Han; Y S Hur; Y C Chu
Journal:  J Korean Med Sci       Date:  2000-10       Impact factor: 2.153

10.  Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment.

Authors:  Gunter Assmann; Marc Molinger; Michael Pfreundschuh; Rainer Bohle; Vincent Zimmer
Journal:  Springerplus       Date:  2014-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.